Endocrine, Diabetes and Reproductive (PHAR3813)
UNIT OF STUDY
This unit of study will cover the therapeutics of endocrine, diabetes and reproductive disorders including the pharmaceutical sciences that underpin such drug therapies. This unit will also include the epidemiology, pathophysiology and clinical features of endocrine, diabetes and reproductive disorders. Through the use of case-based learning, students will participate in the interpretation, application and dissemination of pharmaceutical and pharmacotherapeutic concepts and knowledge. On completion of this unit of study students will be able to apply an understanding of the pharmaceutical sciences to optimising the drug and non-drug therapy of patients with endocrine, diabetes and reproductive disorders. Interprofessional communication and the application of specialist knowledge to implementing pharmacist cognitive services such as clinical interventions and/or medication management review will also be explored. Students will become familiar with drug information software and a number of computerised drug information databases. Role-plays will be used to develop students' communication skills for interaction between pharmacists and their clients (patients, doctors, other health professionals). This unit of study is in parallel to experiential placements.
Further unit of study information
An average of 6 hrs of lectures, 2 hrs of tutorials and 2 hrs experiential placement/week.
Tutorial participation and presentations (10%), OSCE (20%) and final exam (70%)
Faculty/department permission required?
Unit of study rules
All first and second year units of study.
PHAR3811 and PHAR3812 and PHAR3814
Study this unit outside a degree
If you wish to undertake one or more units of study (subjects) for your own interest but not towards a degree, you may enrol in single units as a non-award student.
If you are from another Australian tertiary institution you may be permitted to underake cross-institutional study in one or more units of study at the University of Sydney.